Models for pharmacist-delivered tobacco cessation services: a systematic review

O’Reilly, Emily; Frederick, Emily K.; Palmer, Emma

doi:10.1016/j.japh.2019.05.022

Cited by 18 publications

(12 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Research demonstrates the efficacy and cost-effectiveness of pharmacist-led programs. 25,26 The team deemed a pharmacist-delivered program was the most feasible and sustainable way to integrate smoking cessation into existing inpatient workflows. To further streamline workflows and minimize handoffs in tobacco dependence care, a delegation protocol allowed pharmacists to order NRT (ie, gum, lozenge, and/or patch), without requiring the approval/signature of the attending physician, during the inpatient stay and upon discharge for patients who did not opt-out of pharmacotherapy.…”

Section: Methodsmentioning

confidence: 99%

Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings

et al. 2021

View full text Add to dashboard Cite

Background: Although people who smoke cigarettes are overrepresented among hospital inpatients, few are connected with smoking cessation treatment during their hospitalization. Training, accountability for medication use, and monitoring of all patients position pharmacists well to deliver cessation interventions to all hospitalized patients who smoke. Methods: A large Midwestern University hospital implemented a pharmacist-led smoking cessation intervention. A delegation protocol for hospital pharmacy inpatients who smoked cigarettes gave hospital pharmacists the authority to order nicotine replacement therapy (NRT) during hospitalization and upon discharge, and for referral to the Wisconsin Tobacco Quit Line (WTQL) at discharge. Eligible patients received the smoking cessation intervention unless they actively refused (ie, “opt-out”). The program was pilot tested in phases, with pharmacist feedback between phases, and then implemented hospital-wide. Interviews, surveys, and informal mechanisms identified ways to improve implementation and workflows. Results: Feedback from pharmacists led to changes that improved workflow, training and patient education materials, and enhanced adoption and reach. Refining implementation strategies across pilot phases increased the percentage of eligible smokers offered pharmacist-delivered cessation support from 37% to 76%, prescribed NRT from 2% to 44%, and referred to the WTQL from 3% to 32%. Conclusion: Hospitalizations provide an ideal opportunity for patients to make a tobacco quit attempt, and pharmacists can capitalize on this opportunity by integrating smoking cessation treatment into existing inpatient medication reconciliation workflows. Pharmacist-led implementation strategies developed in this study may be applicable in other inpatient settings.

show abstract

Section: Methodsmentioning

confidence: 99%

Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings

et al. 2021

View full text Add to dashboard Cite

show abstract

“…[7] Community pharmacists have demonstrated their ability to provide a wide range of preventative services across multiple disease states. [8][9][10][11][12] However, research regarding opioid misuse interventions in community pharmacy settings is limited. Descriptive research has shown that lack of confidence, lack of time, unwillingness to communicate with prescribers, limited familiarity with screening materials, and inability to identify patients at risk of overdose all limit pharmacist engagement with patients at risk for substance misuse.…”

Section: Introductionmentioning

confidence: 99%

Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis

Salwan¹,

Hagemeier²,

Tudiver³

et al. 2020

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

“…The framework of the study design was based off of smoking cessation research using a 12-week timeframe, high touch points with participants, and healthcare professionals offering support and guidance [20,21].…”

Section: Methodsmentioning

confidence: 99%

Pilot Study of Electronic Nicotine Delivery Systems (ENDS) Cessation Methods

et al. 2021

View full text Add to dashboard Cite

Currently, 7.6% of the U.S. young adults aged 18–24 years old use e-cigarettes. This study piloted three methods of Electronic Nicotine Delivery Systems (ENDS) cessation by measuring cessation rates, motivational techniques that contributed to cessation success, and participants’ changes after decreasing vape use. Participants were randomized into three study arms (nicotine replacement therapy (NRT) + behavioral support, vape-taper + behavioral support, self-guided) in a 1:1:1 ratio. All participants were invited to attend nine in-person or phone appointments over the 6-month study period. At 12 weeks, 3 of 7 (42.9%) participants in the NRT + behavioral support arm, 6 of 8 (75%) vape-taper + behavioral support arm, and 7 of 9 (77.8%) self-guided arm self-reported being vape-free and nicotine-free. At 6 months, 3 of 7 (42.9%) participants in the NRT + behavioral support arm, 6 of 8 (75%) vape-taper + behavioral support arm, and 4 of 9 (44.4%) self-guided arm self-reported being vape-free and nicotine-free. A challenge to quitting and remain quit is social pressures, but participants identified self-control and establishing new habits to be the best methods to overcome the desire to vape. Participants who received behavioral support and a vape-taper plan from pharmacists were more likely to be vape-free and nicotine-free at 6 months.

show abstract

Models for pharmacist-delivered tobacco cessation services: a systematic review

Cited by 18 publications

References 31 publications

Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings

Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings

Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis

Pilot Study of Electronic Nicotine Delivery Systems (ENDS) Cessation Methods

Contact Info

Product

Resources

About